2-{4-[2-(2,4-Diamino-pteridin-6-yl)-ethyl]-benzoylamino}-pentanedioic acid

ID: ALA293263

Cas Number: 52454-37-2

PubChem CID: 100516

Max Phase: Preclinical

Molecular Formula: C20H21N7O5

Molecular Weight: 439.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: GNF-Pf-173 | 10-Deazaaminopterin|52454-37-2|10-Deazaminopterin|10-Deaza-aminopterin|GNF-PF-173|PXJ16PPE04|CHEMBL293263|L-Glutamic acid, N-(4-(2-(2,4-diamino-6-pteridinyl)ethyl)benzoyl)-|(2S)-2-[[4-[2-(2,4-diaminopteridin-6-yl)ethyl]benzoyl]amino]pentanedioic acid|(4-(2-(2,4-diaminopteridin-6-yl)ethyl)benzoyl)-L-glutamic acid|UNII-PXJ16PPE04|NSC 311469|NSC-311469|10-DAM|SCHEMBL7081697|BDBM50016461|AKOS040746467|HY-125647|CS-0092602|Q27286805|(S)-2-(4-(2-(2,4-Diaminopteridin-6-yl)ethyl)benzamido)pShow More

Canonical SMILES:  Nc1nc(N)c2nc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1

Standard InChI:  InChI=1S/C20H21N7O5/c21-16-15-17(27-20(22)26-16)23-9-12(24-15)6-3-10-1-4-11(5-2-10)18(30)25-13(19(31)32)7-8-14(28)29/h1-2,4-5,9,13H,3,6-8H2,(H,25,30)(H,28,29)(H,31,32)(H4,21,22,23,26,27)/t13-/m0/s1

Standard InChI Key:  LGFLRHWJJKLPCC-ZDUSSCGKSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   -3.6486    1.3517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6111   -0.7486    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964   -1.4973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2928   -2.6973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964   -1.4973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929   -0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8942   -1.4964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1929   -0.7441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4942   -1.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7933   -0.7419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0923   -1.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0923   -2.9919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7933   -3.7419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4943   -2.9919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3906   -3.7449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4308   -3.1467    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3885   -5.2457    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6867   -5.9988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6846   -7.4996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9828   -8.2527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9807   -9.7535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9405  -10.3517    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0187  -10.3556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9893   -5.2533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9934   -4.0533    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0266   -5.8565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5929    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2964    1.4973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.7486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2964    1.4973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 20 19  1  6
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 20 26  1  0
 26 27  1  0
 26 28  2  0
  8 29  1  0
 29 30  2  0
 30 31  1  0
 31  6  1  0
 31 32  2  0
 32  2  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lacticaseibacillus casei (578 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
folA Dihydrofolate reductase (640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dhfr Dihydrofolate reductase (711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecium (13803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
thyA Thymidylate synthase (501 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.43Molecular Weight (Monoisotopic): 439.1604AlogP: 0.42#Rotatable Bonds: 9
Polar Surface Area: 207.30Molecular Species: ACIDHBA: 9HBD: 5
#RO5 Violations: HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.34CX Basic pKa: 2.88CX LogP: 0.27CX LogD: -6.04
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.31Np Likeness Score: -0.17

References

1. Nair MG, Bridges TW, Henkel TJ, Kisliuk RL, Gaumont Y, Sirotnak FM..  (1981)  Folate analogues altered in the C9-N10 bridge region. 18. Synthesis and antitumor evaluation of 11-oxahomoaminopterin and related compounds.,  24  (9): [PMID:6793726] [10.1021/jm00141a010]
2. DeGraw JI, Brown VH, Tagawa H, Kisliuk RL, Gaumont Y, Sirotnak FM..  (1982)  Synthesis and antitumor activity of 10-alkyl-10-deazaminopterins. A convenient synthesis of 10-deazaminopterin.,  25  (10): [PMID:7143361] [10.1021/jm00352a026]
3. Nair MG, Nanavati NT, Kumar P, Gaumont Y, Kisliuk RL..  (1988)  Synthesis and biological evaluation of poly-gamma-glutamyl metabolites of 10-deazaaminopterin and 10-ethyl-10-deazaaminopterin.,  31  (1): [PMID:2447278] [10.1021/jm00396a029]
4. DeGraw JI, Christie PH, Kisliuk RL, Gaumont Y, Sirotnak FM..  (1990)  Synthesis and antifolate properties of 9-alkyl-10-deazaminopterins.,  33  (1): [PMID:2296020] [10.1021/jm00163a035]
5. DeGraw JI, Colwell WT, Piper JR, Sirotnak FM..  (1993)  Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterin.,  36  (15): [PMID:8340923] [10.1021/jm00067a020]
6. Abraham A, McGuire JJ, Galivan J, Nimec Z, Kisliuk RL, Gaumont Y, Nair MG..  (1991)  Folate analogues. 34. Synthesis and antitumor activity of non-polyglutamylatable inhibitors of dihydrofolate reductase.,  34  (1): [PMID:1992121] [10.1021/jm00105a035]
7. DeGraw JI, Colwell WT, Crase J, Smith RL, Piper JR, Waud WR, Sirotnak FM..  (1997)  Analogues of methotrexate in rheumatoid arthritis. 1. Effects of 10-deazaaminopterin analogues on type II collagen-induced arthritis in mice.,  40  (3): [PMID:9022804] [10.1021/jm9505526]

Source